RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

KFU: Vaccine against COVID-19 coronavirus

Product
Developers: Crimean federal university of V.I. Vernadsky
Date of the premiere of the system: October, 2020
Branches: Pharmaceutics, medicine, health care

2020: Vaccine from COVID-19 which can be inhaled is developed

Russia developed the vaccine against a coronavirus of COVID-19 which can be inhaled. It became known on October 15, 2020.

Medicine was created at the Crimean Federal University (CFU) of Vernadsky. According to the associate professor of biochemistry of university, the head of laboratory of cellular technologies and DNA-drugs Vladimir Oberemok, for use of vaccine the injection is not necessary — it can be inhaled through a nose.

File:Aquote1.png
Our original vaccine consists of one oligonukleotid (a thiophosphatic fragment of DNA) in the form of a lasso which bears the activator of congenital immunity in the form of CpG-islands at once and antigen where the small fragment of a genome of SARS-CoV-2 that the organism identified it will "be sewn up" and developed specific antibodies — he explained.
File:Aquote2.png

Russia developed the vaccine against a coronavirus of COVID-19 which can be inhaled

According to the scientist, the CpG-islands which are present at structure of a genome of a coronavirus provoke a so-called tsitokinovy storm and severe forms of a disease with considerable damage of lungs. But since the beginning of a pandemic their quantity decreased, so, lethality from a disease will gradually decrease. After vaccination oligonukleotidy the real threat from infection will not be any more.

Oberemok considers that virus strains which are less dangerous will be fixed in a human population, but are capable to extend promptly.

File:Aquote1.png
It is important to understand that a new coronavirus with us forever. For this reason the competition between different vaccines is necessary to find the most effective of them in a specific situation and to have an alternative in the choice — he emphasized.
File:Aquote2.png

Oberemok also added, specialists are ready to start all test stages of vaccine right after receiving necessary financing. He did not call the expected investment volume into development. Results of development of the Crimean scientists are published in the international scientific magazine Inflammation Research.[1]

Notes